Trial Profile
A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Mar 2024
Price :
$35
*
At a glance
- Drugs Baloxavir-marboxil (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Acronyms Pebblestone
- Sponsors Roche
- 14 Nov 2023 Status changed from not yet recruiting to recruiting.
- 26 Oct 2023 New trial record